Cytokinetics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Cytokinetics
Tip: Access up to 7 years of quarterly data
All positions including Cytokinetics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cytokinetics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $13M | 238k | 54.96 |
| 2025-06-30 | $14M | 416k | 33.04 |
| 2025-03-31 | $12M | 309k | 40.19 |
| 2024-12-31 | $15M | 315k | 47.04 |
| 2024-09-30 | $14M | 267k | 52.80 |
| 2024-06-30 | $14M | 252k | 54.18 |
| 2024-03-31 | $8.3M | 118k | 70.11 |
| 2023-12-31 | $9.7M | 117k | 83.49 |
| 2023-09-30 | $3.6M | 121k | 29.46 |
| 2023-06-30 | $4.1M | 116k | 35.19 |
| 2023-03-31 | $4.1M | 116k | 35.19 |
| 2022-12-31 | $4.5M | 97k | 45.82 |
| 2022-09-30 | $4.0M | 82k | 48.45 |
| 2022-06-30 | $3.9M | 100k | 39.29 |
| 2022-03-31 | $3.4M | 94k | 36.81 |
| 2021-12-31 | $4.3M | 94k | 45.58 |
| 2021-09-30 | $2.5M | 69k | 35.74 |
| 2021-06-30 | $1.2M | 63k | 19.79 |
| 2021-03-31 | $1.5M | 63k | 23.26 |
| 2020-12-31 | $1.1M | 53k | 21.65 |
| 2020-09-30 | $1.1M | 53k | 21.65 |
| 2020-06-30 | $1.1M | 48k | 23.57 |
| 2020-03-31 | $700k | 59k | 11.79 |
| 2019-12-31 | $495k | 47k | 10.61 |
| 2019-09-30 | $660k | 58k | 11.38 |
| 2019-06-30 | $327k | 29k | 11.25 |
| 2019-03-31 | $235k | 29k | 8.09 |
| 2018-12-31 | $166k | 26k | 6.32 |
| 2018-09-30 | $258k | 26k | 9.85 |
| 2018-06-30 | $218k | 26k | 8.30 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas